Shows
DeviceTalks Podcast NetworkCould CereVasc Be Boston’s Next Big MedTech Success Story? The Future of Ortho with The FroIn this episode of the DeviceTalks Weekly Podcast, Tom Salemi talks with seasoned MedTech executive Daniel Levangie about the blood-brain barrier-breaking technology being developed by CereVasc.
The company has developed a less invasive way of treating patients with communicating hydrocephalus, one of the most common neurological conditions affecting both children and adults. But the company’s tech gives physicians access to the brain, creating a potentially huge opportunity for future applications.
Just prior to the keynote interview, Tom talks with orthopedic surgeon and OrthoShow podcast host Scott Sigman, MD, about the Future of Orthopedics, a co...2025-04-191h 06DeviceTalks Podcast NetworkCould CereVasc Be Boston’s Next Big MedTech Success Story? The Future of Ortho with The FroIn this episode of the DeviceTalks Weekly Podcast, Tom Salemi talks with seasoned MedTech executive Daniel Levangie about the blood-brain barrier-breaking technology being developed by CereVasc.
The company has developed a less invasive way of treating patients with communicating hydrocephalus, one of the most common neurological conditions affecting both children and adults. But the company’s tech gives physicians access to the brain, creating a potentially huge opportunity for future applications.
Just prior to the keynote interview, Tom talks with orthopedic surgeon and OrthoShow podcast host Scott Sigman, MD, about the Future of Orthopedics, a co...2025-04-191h 06
DeviceTalks Podcast NetworkCorVista using AI to get patients the correct cardiac care; Why ASCs should matter to MedTechsIn this episode of DeviceTalks Weekly Podcast, Host Tom Salemi tracks the career of CorVista Health CEO Adrian Lam, an engineer turned financer turned VC turned CEO.
CorVista is bringing AI to bear on cardiac diagnostics, helping hospitals and doctors identify who need the most care.
Before that talk we’ll hear from Scott Frasier of Fraser Healthcare about what ambulatory surgery centers mean for the future of MedTech.
Finally, MassDevice Editor Chris Newmarker and Tom talk about the impact President Trump’s tariff tactics are having on the MedTech industry.
This...2025-04-121h 23DeviceTalks Podcast NetworkCorVista using AI to get patients the correct cardiac care; Why ASCs should matter to MedTechsIn this episode of DeviceTalks Weekly Podcast, Host Tom Salemi tracks the career of CorVista Health CEO Adrian Lam, an engineer turned financer turned VC turned CEO.
CorVista is bringing AI to bear on cardiac diagnostics, helping hospitals and doctors identify who need the most care.
Before that talk we’ll hear from Scott Frasier of Fraser Healthcare about what ambulatory surgery centers mean for the future of MedTech.
Finally, MassDevice Editor Chris Newmarker and Tom talk about the impact President Trump’s tariff tactics are having on the MedTech industry.
This...2025-04-121h 23
DeviceTalks Podcast NetworkFogarty’s Cleeland on impact of MedTech innovation; Soriano highlights Baxter’s hurricane responseIn this week’s episode of the DeviceTalks Weekly Podcast, Andrew Cleeland, CEO of the Fogarty Institute, shares his MedTech story, starting with a serendipitous move into the industry. Cleeland, of course, went on to lead two successful startups from The Foundry - Ardian and Twelve, that both went on to be acquired by Medtronic. Cleeland now leads one of the industry’s most successful incubator programs, the Fogarty Institute. Cleeland will share insights on leading a MedTech start-up and shares some concerns he has for the industry at large.
The Fogarty Institute is also promoting the Thoma...2025-03-281h 25DeviceTalks Podcast NetworkFogarty’s Cleeland on impact of MedTech innovation; Soriano highlights Baxter’s hurricane responseIn this week’s episode of the DeviceTalks Weekly Podcast, Andrew Cleeland, CEO of the Fogarty Institute, shares his MedTech story, starting with a serendipitous move into the industry. Cleeland, of course, went on to lead two successful startups from The Foundry - Ardian and Twelve, that both went on to be acquired by Medtronic. Cleeland now leads one of the industry’s most successful incubator programs, the Fogarty Institute. Cleeland will share insights on leading a MedTech start-up and shares some concerns he has for the industry at large.
The Fogarty Institute is also promoting the Thoma...2025-03-281h 25
DeviceTalks Podcast NetworkLotvin on why this Sequel AID is better than the original; ZB’s Tornos highlights new tech, ASCsIn this episode of the DeviceTalks Weekly podcast, Host Tom Salemi interviews Alan Lotvin, MD, the CEO and co-founder of Sequel Med Tech, a small company promoting another BIG idea from prolific inventor Dean Kamen. Lotvin, who was formerly a senior executive at CVS/Caremark and PBMs, explains how Twiist, the automated insulin delivery system, could be a game-changer for people with diabetes.
Before the interview, we’ll hear from Ivan Tornos, the CEO and president of Zimmer Biomet. Tornos, who is the opening keynote interview guest at DeviceTalks Boston on April 30 at the Boston Convention & Exhibition Center talks with Sa...2025-03-211h 04DeviceTalks Podcast NetworkLotvin on why this Sequel AID is better than the original; ZB’s Tornos highlights new tech, ASCsIn this episode of the DeviceTalks Weekly podcast, Host Tom Salemi interviews Alan Lotvin, MD, the CEO and co-founder of Sequel Med Tech, a small company promoting another BIG idea from prolific inventor Dean Kamen. Lotvin, who was formerly a senior executive at CVS/Caremark and PBMs, explains how Twiist, the automated insulin delivery system, could be a game-changer for people with diabetes.
Before the interview, we’ll hear from Ivan Tornos, the CEO and president of Zimmer Biomet. Tornos, who is the opening keynote interview guest at DeviceTalks Boston on April 30 at the Boston Convention & Exhibition Center talks with Sa...2025-03-211h 04
DeviceTalks Podcast NetworkBIOTRONIK Neuro’s Langevin talks power of connected spinal stim; What’s Next in Surgical RoboticsIn this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi interviews Todd Langevin, president of BIOTRONIK Neuro, a familiar name in medical devices with a new approach to alleviating pain through spinal cord stimulation. Langevin, who has spent his career in neuro devices, gives his assessment of the field today, explaining how it’s exceeded his early expectations.
Just before that Tom talks with Joe Mullings of The Mullings Group and Surgical Robotics Expert Steve Bell about the state of the surgical robotics industry. The trio will talk about current leaders, emerging powers, and how a shift toward cardiac su...2025-03-141h 17DeviceTalks Podcast NetworkBIOTRONIK Neuro’s Langevin talks power of connected spinal stim; What’s Next in Surgical RoboticsIn this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi interviews Todd Langevin, president of BIOTRONIK Neuro, a familiar name in medical devices with a new approach to alleviating pain through spinal cord stimulation. Langevin, who has spent his career in neuro devices, gives his assessment of the field today, explaining how it’s exceeded his early expectations.
Just before that Tom talks with Joe Mullings of The Mullings Group and Surgical Robotics Expert Steve Bell about the state of the surgical robotics industry. The trio will talk about current leaders, emerging powers, and how a shift toward cardiac su...2025-03-141h 17
DeviceTalks Podcast NetworkWhy Penumbra CEO Adam Elsesser will take uncertainty over risk in MedTech innovationIn this episode of the DeviceTalks Weekly Podcast, we’ll play the interview Host Tom Salemi conducted with Adam Elsesser, CEO of Penumbra, which has grown into a force in the vascular and neurovascular industries.
Elsesser’s path into running a MedTech startup was quite accidental, but that unorthodox path has helped the company develop a unique culture for innovation. Elsesser shares that philosophy in this interview and explains why he prefers uncertainty over risk.
Kicking off the episode Jim Hammerand, managing editor of Medical Design and Outsourcing, visits with Chris Newmarker and Salemi to share the highlights of the maga...2025-01-101h 07DeviceTalks Podcast NetworkWhy Penumbra CEO Adam Elsesser will take uncertainty over risk in MedTech innovationIn this episode of the DeviceTalks Weekly Podcast, we’ll play the interview Host Tom Salemi conducted with Adam Elsesser, CEO of Penumbra, which has grown into a force in the vascular and neurovascular industries.
Elsesser’s path into running a MedTech startup was quite accidental, but that unorthodox path has helped the company develop a unique culture for innovation. Elsesser shares that philosophy in this interview and explains why he prefers uncertainty over risk.
Kicking off the episode Jim Hammerand, managing editor of Medical Design and Outsourcing, visits with Chris Newmarker and Salemi to share the highlights of the maga...2025-01-101h 07
DeviceTalks Podcast NetworkFlow Medical CEO Fried sees huge opportunity to clear pulmonary embolisms; State of DeviceTalksIn this episode of the DeviceTalks Weekly podcast, Flow Medical CEO Jennifer Fried tells Host Tom Salemi the story of the MedTech startup that recently closed on a $5 million seed round.
The story checks all the boxes of a great MedTech story.
Physicians Dr. Jonathan Paul and Dr. Osman Ahmed crafted the idea of a new angiography, infusion, and monitoring catheter that could be used to dissolve pulmonary embolism. The napkin drawing grew into a company led by Fried, who had already exited her first startup. Now, with funds in hands, Flow Medical is moving into pre-clinical trials.
Before the...2025-01-031h 06DeviceTalks Podcast NetworkFlow Medical CEO Fried sees huge opportunity to clear pulmonary embolisms; State of DeviceTalksIn this episode of the DeviceTalks Weekly podcast, Flow Medical CEO Jennifer Fried tells Host Tom Salemi the story of the MedTech startup that recently closed on a $5 million seed round.
The story checks all the boxes of a great MedTech story.
Physicians Dr. Jonathan Paul and Dr. Osman Ahmed crafted the idea of a new angiography, infusion, and monitoring catheter that could be used to dissolve pulmonary embolism. The napkin drawing grew into a company led by Fried, who had already exited her first startup. Now, with funds in hands, Flow Medical is moving into pre-clinical trials.
Before the...2025-01-031h 06
DeviceTalks Podcast NetworkHow Perimeter Medical hopes to use OCT & AI to boost surgeon confidence & patient peace of mindIn this episode of DeviceTalks Weekly, we’ll hear how Perimeter Medical Imaging AI hopes to help surgeons get a clearer picture of whether they removed all cancerous tissue in a surgical procedure. CEO Adrian Mendes explains why 20% of patients who have undergone a lumpectomy must undergo a second operation to remove cancerous tissue that had been missed. Perimeter recently released the positive results from its pivotal study showing it more effectively addressed residual cancer at the surgical margin during surgery as compared to current standard methods. The company is planning to file a PMA with the FDA. Mendes also ta...2024-12-131h 13DeviceTalks Podcast NetworkHow Perimeter Medical hopes to use OCT & AI to boost surgeon confidence & patient peace of mindIn this episode of DeviceTalks Weekly, we’ll hear how Perimeter Medical Imaging AI hopes to help surgeons get a clearer picture of whether they removed all cancerous tissue in a surgical procedure. CEO Adrian Mendes explains why 20% of patients who have undergone a lumpectomy must undergo a second operation to remove cancerous tissue that had been missed. Perimeter recently released the positive results from its pivotal study showing it more effectively addressed residual cancer at the surgical margin during surgery as compared to current standard methods. The company is planning to file a PMA with the FDA. Mendes also ta...2024-12-131h 13
DeviceTalks Podcast NetworkPhagenesis CEO Hoskins on helping stroke survivors recover; How Distalmotion will target ASCsIn this episode of DeviceTalks Weekly, Tom Salemi and Chris Newmarker tackle some of the weeks’ biggest news including the FDA giving a nod to Distalmotion’s Dexter robot and the Yankees blowing the World Series.
Distalmotion CEO Greg Roche visits to share his thoughts on both. Then Tom interviews Chad Hoskins, CEO of Phagenesis, a startup developing a neurostimulation device that could help stroke survivors recover.
This week’s Newmaker’s Newsmakers include Medtronic, Masimo, Exactech, Solventum and you already know about this week’s number one.
This episode is sponsored by DeviceTalks Boston. Register now at Boston.DeviceTalks.com.
Thank...2024-11-011h 15DeviceTalks Podcast NetworkPhagenesis CEO Hoskins on helping stroke survivors recover; How Distalmotion will target ASCsIn this episode of DeviceTalks Weekly, Tom Salemi and Chris Newmarker tackle some of the weeks’ biggest news including the FDA giving a nod to Distalmotion’s Dexter robot and the Yankees blowing the World Series.
Distalmotion CEO Greg Roche visits to share his thoughts on both. Then Tom interviews Chad Hoskins, CEO of Phagenesis, a startup developing a neurostimulation device that could help stroke survivors recover.
This week’s Newmaker’s Newsmakers include Medtronic, Masimo, Exactech, Solventum and you already know about this week’s number one.
This episode is sponsored by DeviceTalks Boston. Register now at Boston.DeviceTalks.com.
Thank...2024-11-011h 15
DeviceTalks Podcast NetworkHear Kandu’s mission to empower stroke survivors, Medtronic’s Goodheart on lifting women in MedTechIn this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi chats with Managing Editor Kayleen Brown about the upcoming DeviceTalks West meeting. This week’s episode features an interview Brown did with Medtronic’s Nina Goodheart at the Women in Medtech Breakfast at DeviceTalks Boston. The conversation previews the Women in Medtech Luncheon interview featuring Cecilia Soriano, president, infusion therapies and technologies, at Baxter International. In our second interview, Salemi interviews Kirsten Carroll, CEO of Kandu Health about that company’s work to empower stroke survivors. Carroll will be speaking at DeviceTalks West.
Register at West.DeviceTalks.com to regist...2024-09-141h 01DeviceTalks Podcast NetworkHear Kandu’s mission to empower stroke survivors, Medtronic’s Goodheart on lifting women in MedTechIn this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi chats with Managing Editor Kayleen Brown about the upcoming DeviceTalks West meeting. This week’s episode features an interview Brown did with Medtronic’s Nina Goodheart at the Women in Medtech Breakfast at DeviceTalks Boston. The conversation previews the Women in Medtech Luncheon interview featuring Cecilia Soriano, president, infusion therapies and technologies, at Baxter International. In our second interview, Salemi interviews Kirsten Carroll, CEO of Kandu Health about that company’s work to empower stroke survivors. Carroll will be speaking at DeviceTalks West.
Register at West.DeviceTalks.com to regist...2024-09-141h 01
DeviceTalks Podcast NetworkBoston Scientific’s Baker on how Intracept battles back pain. Hear full story at DeviceTalks WestIn this episode of DeviceTalks Weekly podcast, Host Tom Salemi introduces one DeviceTalks West speaker. Ray Baker, MD, vice president and chief medical officer, neuromodulation at Boston Scientific, introduces DeviceTalks Weekly listeners to Intracept, a procedure approved by the FDA to treat forms of back pain. Dr. Baker will be a speaker at DeviceTalks West on Oct. 17 where the clinical and commercial details will be discussed.
Register now at West.Devicetalks.com. Use the code mentioned in the podcast to save 25% off the price of registration.
Salemi also invites listeners to attend the Connected Health Series taking place Sept. 10-12...2024-09-071h 00DeviceTalks Podcast NetworkBoston Scientific’s Baker on how Intracept battles back pain. Hear full story at DeviceTalks WestIn this episode of DeviceTalks Weekly podcast, Host Tom Salemi introduces one DeviceTalks West speaker. Ray Baker, MD, vice president and chief medical officer, neuromodulation at Boston Scientific, introduces DeviceTalks Weekly listeners to Intracept, a procedure approved by the FDA to treat forms of back pain. Dr. Baker will be a speaker at DeviceTalks West on Oct. 17 where the clinical and commercial details will be discussed.
Register now at West.Devicetalks.com. Use the code mentioned in the podcast to save 25% off the price of registration.
Salemi also invites listeners to attend the Connected Health Series taking place Sept. 10-12...2024-09-071h 00
The Leading DifferenceTom Salemi | Editorial Director, DeviceTalks | MedTech Storytelling, Event Collaboration, & the Power of ConnectionTom Salemi, editorial director of DeviceTalks shares his accidental yet fulfilling journey into the medtech industry. Tom reveals his passion for storytelling, building communities, and highlighting the human aspect of medical device innovation. He discusses the evolution of DeviceTalks, its focus on collaboration and education, and the importance of personal connections within the industry.
Guest links: devicetalks.com
Charity supported: Feeding America
Interested in being a guest on the show or have feedback to share? Email us at podcast@velentium.com.
PRODUCTION CREDITS
Host: Lindsey Dinneen
Editi...2024-08-0930 minThe Leading DifferenceTom Salemi | Editorial Director, DeviceTalks | MedTech Storytelling, Event Collaboration, & the Power of ConnectionTom Salemi, editorial director of DeviceTalks shares his accidental yet fulfilling journey into the medtech industry. Tom reveals his passion for storytelling, building communities, and highlighting the human aspect of medical device innovation. He discusses the evolution of DeviceTalks, its focus on collaboration and education, and the importance of personal connections within the industry.
Guest links: devicetalks.com
Charity supported: Feeding America
Interested in being a guest on the show or have feedback to share? Email us at podcast@velentium.com.
PRODUCTION CREDITS
Host: Lindsey Dinneen
Editi...2024-08-0930 min
DeviceTalks Podcast NetworkBoston Scientific Interventional CMO talks CAD, stents, drug-coated balloons and the lure of historyIn this episode of the DeviceTalks Weekly podcast, Host Tom Salemi speaks with Dr. Janar Sathananthan, chief medical officer of Boston Scientific’s interventional cardiology therapies business about the coronary artery disease, stenting and its AGENT drug-coated balloon.
This episode is sponsored by Freudenberg Medical. For more information, please visit www.freudenbergmedical.com.
MassDevice’s Chris Newmarker and Sean Whooley join the Newmarker’s Newsmakers section to talk about the big MedTech story of the week as well as the news coming out of the American Diabetes Association annual meeting.
Salemi also shares some thoughts from the Annual Meeting of the So...2024-06-281h 09DeviceTalks Podcast NetworkBoston Scientific Interventional CMO talks CAD, stents, drug-coated balloons and the lure of historyIn this episode of the DeviceTalks Weekly podcast, Host Tom Salemi speaks with Dr. Janar Sathananthan, chief medical officer of Boston Scientific’s interventional cardiology therapies business about the coronary artery disease, stenting and its AGENT drug-coated balloon.
This episode is sponsored by Freudenberg Medical. For more information, please visit www.freudenbergmedical.com.
MassDevice’s Chris Newmarker and Sean Whooley join the Newmarker’s Newsmakers section to talk about the big MedTech story of the week as well as the news coming out of the American Diabetes Association annual meeting.
Salemi also shares some thoughts from the Annual Meeting of the So...2024-06-281h 09
Home Court Health with Tom FooleryEP 63 - Mastering the Masculine with Mike SalemiMike Salemi has been a force to be reckoned with in nearly every pursuit he has chosen... and now, as a father, he seems fit to this most dynamic of tasks. I sought Mike out because of how he shows up as a leader for Men, presenting the most useful and universal messages on his chosen platforms. When Mike appeared as a visiting expert for my recent men's work, I was struck by his earnest desire to make an impact, without forcing anything - just simply bringing the best he could offer (which was a g...2024-06-101h 03
DeviceTalks Podcast NetworkHow Akura Medical wants to advance thrombectomy; What does da Vinci 5 mean for surgical robotics?In this episode of DeviceTalks Weekly Co-Hosts Tom Salemi and Chris Newmarker pay a visit to the Wizard, Joe Mullings of The Mullings Group, to get his take on the disruptive force that is Intuitive’s da Vinci 5. What does this mean to the surgical robotics competitors both big and small?
Then Tom Salemi talks with Murali Srivathsa, CEO of Akura Medical, about the company’s aggressive moves to disrupt the thrombectomy. Akura is part of the prolific Shifamed accelerator, so we’ll talk about that innovative powerhouse as well as Srivathasa’s own career.
To register for the upcoming DeviceTa...2024-03-151h 13DeviceTalks Podcast NetworkHow Akura Medical wants to advance thrombectomy; What does da Vinci 5 mean for surgical robotics?In this episode of DeviceTalks Weekly Co-Hosts Tom Salemi and Chris Newmarker pay a visit to the Wizard, Joe Mullings of The Mullings Group, to get his take on the disruptive force that is Intuitive’s da Vinci 5. What does this mean to the surgical robotics competitors both big and small?
Then Tom Salemi talks with Murali Srivathsa, CEO of Akura Medical, about the company’s aggressive moves to disrupt the thrombectomy. Akura is part of the prolific Shifamed accelerator, so we’ll talk about that innovative powerhouse as well as Srivathasa’s own career.
To register for the upcoming DeviceTa...2024-03-151h 13
DeviceTalks Podcast NetworkWhat the spaceMIRA Mission Means for Surgical Robots; Cyborgs, Drill Pills & Other Cool Harvard TechIn this episode of the DeviceTalks Weekly podcast, John Murphy, CEO of Virtual Incision, highlights the headline-grabbing surgical robotics start-up. Virtual Incision followed up a trip to the ISS for a nod from the FDA. What’s next? He talks to Editorial Director, Tom Salemi.
But first Shriya Srinivasan, Ph.d, assistant professor at Harvard’s School of Engineering and Applied Sciences, drops some SciFi on Salemi and Chris Newmarker – neuro interfaces, tiny drills that deliver drugs, and much more! Srinivasan will bring her insights to DeviceTalks Boston on May 1!
Thanks to DornerWorks for sponsoring this episode. Find out more at Dor...2024-03-081h 22DeviceTalks Podcast NetworkWhat the spaceMIRA Mission Means for Surgical Robots; Cyborgs, Drill Pills & Other Cool Harvard TechIn this episode of the DeviceTalks Weekly podcast, John Murphy, CEO of Virtual Incision, highlights the headline-grabbing surgical robotics start-up. Virtual Incision followed up a trip to the ISS for a nod from the FDA. What’s next? He talks to Editorial Director, Tom Salemi.
But first Shriya Srinivasan, Ph.d, assistant professor at Harvard’s School of Engineering and Applied Sciences, drops some SciFi on Salemi and Chris Newmarker – neuro interfaces, tiny drills that deliver drugs, and much more! Srinivasan will bring her insights to DeviceTalks Boston on May 1!
Thanks to DornerWorks for sponsoring this episode. Find out more at Dor...2024-03-081h 22
DeviceTalks Podcast NetworkHow MedTech Color’s Pitch Competition Startup Finalists Are Tackling Healthcare’s Biggest ProblemsIn this episode of the DeviceTalks Weekly podcast, we meet the 13 finalists for the MedTech Color Pitch Competition, both general and pediatric categories.
Editorial Director Tom Salemi and Managing Editor Kayleen Brown ask each entrepreneur about the problems they’re trying to solve and the solutions they’ve developed.
Tom and Kayleen also interview MedTech Color’s new executive director, Katrina Holland. The pitch competition takes place March 15.
For the list of finalists and registration information go to MedTechColor.org
Thank you for listening to the DeviceTalks Weekly Podcast.
Please subscribe to the DeviceTalks Podcast Network on any major podcast player2024-03-021h 39DeviceTalks Podcast NetworkHow MedTech Color’s Pitch Competition Startup Finalists Are Tackling Healthcare’s Biggest ProblemsIn this episode of the DeviceTalks Weekly podcast, we meet the 13 finalists for the MedTech Color Pitch Competition, both general and pediatric categories.
Editorial Director Tom Salemi and Managing Editor Kayleen Brown ask each entrepreneur about the problems they’re trying to solve and the solutions they’ve developed.
Tom and Kayleen also interview MedTech Color’s new executive director, Katrina Holland. The pitch competition takes place March 15.
For the list of finalists and registration information go to MedTechColor.org
Thank you for listening to the DeviceTalks Weekly Podcast.
Please subscribe to the DeviceTalks Podcast Network on any major podcast player2024-03-021h 39
DeviceTalks Podcast NetworkInnovHeart CEO Wilson shares vision for TMVR start-up; Our chat with AAOS pitch winner CytexOrthoIn this episode of the DeviceTalks Weekly Podcast, Co-hosts Tom Salemi and Chris Newmarker interview Brad Estes, CEO of CytexOrtho, the winner of a pitch contest staged by AAOS. The company is developing implants that could serve as an alternative therapy to total hip replacement.
In our main interview, Tom interviews David Wilson, CEO of InnovHeart, a multinational startup that’s developing transcatheter mitral valve replacement systems to treat patients with mitral valve disease. Wilson talks about his journey into medtech, his decision to shift from engineering to sales, and how life as a global president of a medical device bu...2024-02-231h 01DeviceTalks Podcast NetworkInnovHeart CEO Wilson shares vision for TMVR start-up; Our chat with AAOS pitch winner CytexOrthoIn this episode of the DeviceTalks Weekly Podcast, Co-hosts Tom Salemi and Chris Newmarker interview Brad Estes, CEO of CytexOrtho, the winner of a pitch contest staged by AAOS. The company is developing implants that could serve as an alternative therapy to total hip replacement.
In our main interview, Tom interviews David Wilson, CEO of InnovHeart, a multinational startup that’s developing transcatheter mitral valve replacement systems to treat patients with mitral valve disease. Wilson talks about his journey into medtech, his decision to shift from engineering to sales, and how life as a global president of a medical device bu...2024-02-231h 01
DeviceTalks Podcast NetworkJ&Js Tezel Says Tapping Global Network and Diverse Engineering Disciplines Strengthens Medtech R&DWe’ll open this week’s episode with Paul Grand, CEO of the MedTech Innovator. Grand issued a last call for medical device entrepreneurs to apply to be part of this year’s program. Lots of good stuff come with it. Listen to the episode and apply at MedTechInnovator.org.
Then Co-Hosts Tom Salemi and Chris Newmarker interview successful startup CEO Bill Gruber about his new book, The Leadership Blueprint. Gruber shares some experiences and lessons, but entrepreneurs are encouraged to buy the book on Amazon.
Finally, Tom Salemi interviews Ahmet Tezel, Company Group Chairman and Global Head of J&J MedT...2024-01-271h 24DeviceTalks Podcast NetworkJ&Js Tezel Says Tapping Global Network and Diverse Engineering Disciplines Strengthens Medtech R&DWe’ll open this week’s episode with Paul Grand, CEO of the MedTech Innovator. Grand issued a last call for medical device entrepreneurs to apply to be part of this year’s program. Lots of good stuff come with it. Listen to the episode and apply at MedTechInnovator.org.
Then Co-Hosts Tom Salemi and Chris Newmarker interview successful startup CEO Bill Gruber about his new book, The Leadership Blueprint. Gruber shares some experiences and lessons, but entrepreneurs are encouraged to buy the book on Amazon.
Finally, Tom Salemi interviews Ahmet Tezel, Company Group Chairman and Global Head of J&J MedT...2024-01-271h 24
DeviceTalks Podcast NetworkFluidda’s De Backer, FastWave’s Nelson Share Individual Strategies for Breaking into Medtech MarketsIn this podcast we’ll talk with two CEOs scaling tall Medtech mountains. First, co-hosts Chris Newsmarker and Tom Salemi chat with Jan De Backer, CEO of Fluidda, developer of a novel new diagnostic tool for respiratory health. De Backer explains how his company is trying to bypass hospitals and build a new commercial path to patients. Then, Salemi talks with Scott Nelson, CEO of FastWave Medical, an innovative new company developing a new intravascular lithotripsy device. How does the start-up intend to compete with market leader Shockwave Medical?
Thank you for listening to this episode of the DeviceTalks Weekly Po...2024-01-191h 12DeviceTalks Podcast NetworkFluidda’s De Backer, FastWave’s Nelson Share Individual Strategies for Breaking into Medtech MarketsIn this podcast we’ll talk with two CEOs scaling tall Medtech mountains. First, co-hosts Chris Newsmarker and Tom Salemi chat with Jan De Backer, CEO of Fluidda, developer of a novel new diagnostic tool for respiratory health. De Backer explains how his company is trying to bypass hospitals and build a new commercial path to patients. Then, Salemi talks with Scott Nelson, CEO of FastWave Medical, an innovative new company developing a new intravascular lithotripsy device. How does the start-up intend to compete with market leader Shockwave Medical?
Thank you for listening to this episode of the DeviceTalks Weekly Po...2024-01-191h 12
DeviceTalks Podcast NetworkWill 2024 Bring Medtech More Promise or More Pain? HSBC’s Norris on Investments, Investors and ExitsIn the first episode of 2024, co-hosts Tom Salemi and Chris Newmarker bring Jonathan Norris, managing director of HSBC Innovation Banking, into the booth to review the medtech portion of the HSBC Venture Healthcare Report. Last year wasn’t medtech’s strongest, but Jon Norris gives entrepreneurs actionable advice and reason for hope. You can find the entire report on the Linked. Check the feed of Norris and Salemi for a link to the report. Or go here https://www.linkedin.com/feed/update/urn:li:activity:7148682579204800512/
Thanks for listening to the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network to r...2024-01-0653 minDeviceTalks Podcast NetworkWill 2024 Bring Medtech More Promise or More Pain? HSBC’s Norris on Investments, Investors and ExitsIn the first episode of 2024, co-hosts Tom Salemi and Chris Newmarker bring Jonathan Norris, managing director of HSBC Innovation Banking, into the booth to review the medtech portion of the HSBC Venture Healthcare Report. Last year wasn’t medtech’s strongest, but Jon Norris gives entrepreneurs actionable advice and reason for hope. You can find the entire report on the Linked. Check the feed of Norris and Salemi for a link to the report. Or go here https://www.linkedin.com/feed/update/urn:li:activity:7148682579204800512/
Thanks for listening to the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network to r...2024-01-0653 min
DeviceTalks Podcast NetworkIt’s the DeviceTalks West Post Game Wrap Up Show, Starring Tom, Chris, Kayleen, Sean and Joe!!We recorded this episode on stage at the conclusion of DeviceTalks West. Our semi-esteemed panel included Co-Hosts Tom Salemi and Chris Newmarker as well as Sean Whooley of the Fast Five Podcast, Kayleen Brown of DeviceTalks, and Joe Mullings of The Mullings Group. We hit upon the highlights of DeviceTalks West. We hope you were there to enjoy the show yourself! Thanks to everyone who made #DTWest2023 such a huge success! Go Medtech!2023-10-2043 minDeviceTalks Podcast NetworkIt’s the DeviceTalks West Post Game Wrap Up Show, Starring Tom, Chris, Kayleen, Sean and Joe!!We recorded this episode on stage at the conclusion of DeviceTalks West. Our semi-esteemed panel included Co-Hosts Tom Salemi and Chris Newmarker as well as Sean Whooley of the Fast Five Podcast, Kayleen Brown of DeviceTalks, and Joe Mullings of The Mullings Group. We hit upon the highlights of DeviceTalks West. We hope you were there to enjoy the show yourself! Thanks to everyone who made #DTWest2023 such a huge success! Go Medtech!2023-10-2043 min
DeviceTalks Podcast NetworkHear the Last 10 Start-ups Standing in MedTech Innovator’s Pitch CompetitionsThis week’s episode is dedicated entirely to the 10 Finalists of MedTech Innovator’s Pitch Competitions. The final winners will be selected by the audience on Oct. 10 at the upcoming AdvaMed annual meeting.
The finalists for MedTech Innovator’s grand prize of $350,000 are listed below. Click on the link to watch their 1-minute pitch video.
Dr. Tom McClellan - Fingy3D - https://www.youtube.com/watch?v=KCoj_ZALf3c
Amanda French - IFPx - https://www.youtube.com/watch?v=8B3j2weOkNo
Jay Shah/Vivek Ganesh - Neurava - https://www.youtube.com/watch?v=lyUB9WCLeww
Dr. Al...2023-09-301h 15DeviceTalks Podcast NetworkHear the Last 10 Start-ups Standing in MedTech Innovator’s Pitch CompetitionsThis week’s episode is dedicated entirely to the 10 Finalists of MedTech Innovator’s Pitch Competitions. The final winners will be selected by the audience on Oct. 10 at the upcoming AdvaMed annual meeting.
The finalists for MedTech Innovator’s grand prize of $350,000 are listed below. Click on the link to watch their 1-minute pitch video.
Dr. Tom McClellan - Fingy3D - https://www.youtube.com/watch?v=KCoj_ZALf3c
Amanda French - IFPx - https://www.youtube.com/watch?v=8B3j2weOkNo
Jay Shah/Vivek Ganesh - Neurava - https://www.youtube.com/watch?v=lyUB9WCLeww
Dr. Al...2023-09-301h 15
DeviceTalks Podcast NetworkShifamed Start-Up Tioga Cardiovascular looking to redefine mitral and tricuspid valve replacementIn this podcast episode, Co-Hosts Tom Salemi and Chris Newmarker review how the medtech industry is handing the current shrinking job market. They’ll review this week’s Newmarker’s Newsmakers which includes Medtronic, Biosense Webster, Johnson & Johnson and high profile clinical meetings. Tom then interviews Mike Dineen, CEO of Tioga Cardiovascular, which is pushing the limits for heart valves. Tioga emerged from the prolific Shifamed incubator. Dineen gives history on both Shifamed and Tioga.
To learn more about the FTC’s review of non-competes go here. https://www.ftc.gov/news-events/news/press-releases/2023/03/ftc-extends-public-comment-period-its-proposed-rule-ban-noncompete-clauses-until-april-19
Thanks for listening to the DeviceTa...2023-03-1151 minDeviceTalks Podcast NetworkShifamed Start-Up Tioga Cardiovascular looking to redefine mitral and tricuspid valve replacementIn this podcast episode, Co-Hosts Tom Salemi and Chris Newmarker review how the medtech industry is handing the current shrinking job market. They’ll review this week’s Newmarker’s Newsmakers which includes Medtronic, Biosense Webster, Johnson & Johnson and high profile clinical meetings. Tom then interviews Mike Dineen, CEO of Tioga Cardiovascular, which is pushing the limits for heart valves. Tioga emerged from the prolific Shifamed incubator. Dineen gives history on both Shifamed and Tioga.
To learn more about the FTC’s review of non-competes go here. https://www.ftc.gov/news-events/news/press-releases/2023/03/ftc-extends-public-comment-period-its-proposed-rule-ban-noncompete-clauses-until-april-19
Thanks for listening to the DeviceTa...2023-03-1151 min
DeviceTalks Podcast NetworkHear what you will see at next week’s DeviceTalks WestEditorial Director Tom Salemi provides a sneak peek (listen?) into next week’s DeviceTalks West conference which will be held Oct. 19-20 at the Santa Clara Convention Center. Tom will run through some of the highlights of the agenda which can be viewed at west.devicetalks.com. We also include snippets of past interviews of two keynotes – Gary Guthart, CEO of Intuitive, and Leslie Trigg, CEO of Outset Medical – from past interviews with DeviceTalks. You can find both interviews on DeviceTalks.com. If you’re interested in attending connect with Tom Salemi on LinkedIn.
Thanks for listening to the DeviceTalks Weekly P...2022-10-1530 minDeviceTalks Podcast NetworkHear what you will see at next week’s DeviceTalks WestEditorial Director Tom Salemi provides a sneak peek (listen?) into next week’s DeviceTalks West conference which will be held Oct. 19-20 at the Santa Clara Convention Center. Tom will run through some of the highlights of the agenda which can be viewed at west.devicetalks.com. We also include snippets of past interviews of two keynotes – Gary Guthart, CEO of Intuitive, and Leslie Trigg, CEO of Outset Medical – from past interviews with DeviceTalks. You can find both interviews on DeviceTalks.com. If you’re interested in attending connect with Tom Salemi on LinkedIn.
Thanks for listening to the DeviceTalks Weekly P...2022-10-1530 min
DeviceTalks Podcast NetworkEthicon’s Tom O’Brien explains the design – and critical need for - its new surgical staplerIn this episode, Tom O’Brien, Ethicon’s worldwide president of endomechanical, gives a detailed lesson on the design of its Echelon 3000 surgical stapler, from recognizing the huge problem of surgical complications and identifying how to build a stapler that’s more suited to ALL surgeons. The Echelon 3000 is designed with 39% greater jaw aperture and a 27% greater articulation span, as well as software that provides real-time haptic and audible device feedback to help enable surgeons to make critical adjustments during procedures.
Executive Editor Life Sciences Chris Newmarker conducts that interview and brings his Newmarker’s Newsmakers hitting upon news from Stryker...2022-07-2948 minDeviceTalks Podcast NetworkEthicon’s Tom O’Brien explains the design – and critical need for - its new surgical staplerIn this episode, Tom O’Brien, Ethicon’s worldwide president of endomechanical, gives a detailed lesson on the design of its Echelon 3000 surgical stapler, from recognizing the huge problem of surgical complications and identifying how to build a stapler that’s more suited to ALL surgeons. The Echelon 3000 is designed with 39% greater jaw aperture and a 27% greater articulation span, as well as software that provides real-time haptic and audible device feedback to help enable surgeons to make critical adjustments during procedures.
Executive Editor Life Sciences Chris Newmarker conducts that interview and brings his Newmarker’s Newsmakers hitting upon news from Stryker...2022-07-2948 min
DeviceTalks Podcast NetworkLobo and Pierce talk Wright, cool tech, robotics and the not-so-secret plans to keep Stryker growingIn this episode, we’ll do a deep dive with Stryker Corp., which recently hosted an in-person analyst day.
In our first interview Andy Pierce, group president of MedSurg and Neurotechnology, will update us on his group’s wide-ranging portfolio, including an artificial intelligence-enabled tool to save the lives of patients at risk of dying of post-partem hemorrhaging.
Kevin Lobo, chair and CEO, visits next to update on the company’s plans to keep building on its market leader status. We’ll talk about the Wright Medical integration, what makes a good acquisition, and how the rise of surgical robotics is helpi...2021-12-031h 16
DeviceTalks Podcast NetworkDT Weekly Roadshow: Five critical changes the Medtech industry has experienced over past two yearsThis week’s discussion begins on the stage in Las Vegas where Tom Salemi interviewed Kwame Ulmer of Ulmer Ventures and Medtech Color at Medmarc’s annual broker meeting.
This episode is sponsored by Medmarc.
The conversation hit upon five areas that have changed over the past two years due to the pandemic or critical concerns over equity and fairness.
In this podcast, Ulmer speaks to the slow progress being made in medtech in diversifying the workforce. But he also offers signs of hope and introduced Medtech Color.
Ulmer will also speak to improvements made at the FDA, where he star...2021-11-191h 05DeviceTalks Podcast NetworkDT Weekly Roadshow: Five critical changes the Medtech industry has experienced over past two yearsThis week’s discussion begins on the stage in Las Vegas where Tom Salemi interviewed Kwame Ulmer of Ulmer Ventures and Medtech Color at Medmarc’s annual broker meeting.
This episode is sponsored by Medmarc.
The conversation hit upon five areas that have changed over the past two years due to the pandemic or critical concerns over equity and fairness.
In this podcast, Ulmer speaks to the slow progress being made in medtech in diversifying the workforce. But he also offers signs of hope and introduced Medtech Color.
Ulmer will also speak to improvements made at the FDA, where he star...2021-11-191h 05
DeviceTalks Podcast NetworkWe interrupt this DeviceTalks Weekly podcast with breaking news about a new podcast!Co-hosts Tom Salemi and Chris Newmarker announce the newest member of the DeviceTalks Podcast family - IntuitiveTalks!2021-10-0804 minDeviceTalks Podcast NetworkWe interrupt this DeviceTalks Weekly podcast with breaking news about a new podcast!Co-hosts Tom Salemi and Chris Newmarker announce the newest member of the DeviceTalks Podcast family - IntuitiveTalks!2021-10-0804 min
DeviceTalks Podcast NetworkHow Abbott and Cordis are working to change the interventional vascular businessLet's get interventional. This week, we talk with leaders from Abbott and Cordis about their plans to advance of medtech's stablest business. Duke Rohlen, executive chair, will explain to co-host Tom Salemi why he led the purchase of Cordis from Cardinal. Meanwhile, Dr. Nick West, CMO and DVP of vascular at Abbott, updates Associated Editor Sean Whooley on the Xience pipeline.
This week's Newmarker's Newsmakers brings the big news from Abbott, Heartflow, Intersect ENT, Intuitive, Medtronic, Philips, and Resmed.
Subscribe to this podcast on all major podcast applications!2021-08-131h 03DeviceTalks Podcast NetworkHow Abbott and Cordis are working to change the interventional vascular businessLet's get interventional. This week, we talk with leaders from Abbott and Cordis about their plans to advance of medtech's stablest business. Duke Rohlen, executive chair, will explain to co-host Tom Salemi why he led the purchase of Cordis from Cardinal. Meanwhile, Dr. Nick West, CMO and DVP of vascular at Abbott, updates Associated Editor Sean Whooley on the Xience pipeline.
This week's Newmarker's Newsmakers brings the big news from Abbott, Heartflow, Intersect ENT, Intuitive, Medtronic, Philips, and Resmed.
Subscribe to this podcast on all major podcast applications!2021-08-131h 03
DeviceTalks Podcast NetworkMakower making medtech innovation bigger, stronger; Medtronic’s Ha speaking up for AAPI colleaguesThis week we’ll explore innovation and social equity.
First, we’ll hear a portion of an interview with Martha Ha, chief privacy officer and chief counsel of corporate governance, and Jon de Csepel, CMO, vice president, medical affairs of the Americas. The pair will explain how the company is reaching out to employees of Asia and Pacific Island and helping them to understand how to better work within the corporate culture. The entire interview can be heard in the latest MedtronicTalks Podcast
Josh Makower, MD, is our closing keynote guest. Makower quite possibly invented modern day medtech innovation. In this...2021-05-281h 02DeviceTalks Podcast NetworkMakower making medtech innovation bigger, stronger; Medtronic’s Ha speaking up for AAPI colleaguesThis week we’ll explore innovation and social equity.
First, we’ll hear a portion of an interview with Martha Ha, chief privacy officer and chief counsel of corporate governance, and Jon de Csepel, CMO, vice president, medical affairs of the Americas. The pair will explain how the company is reaching out to employees of Asia and Pacific Island and helping them to understand how to better work within the corporate culture. The entire interview can be heard in the latest MedtronicTalks Podcast
Josh Makower, MD, is our closing keynote guest. Makower quite possibly invented modern day medtech innovation. In this...2021-05-281h 02
MedtronicTalksEarth Day: Cassidy, Pommier explain how Medtronic is taking many steps toward a smaller footprintIn this episode of the MedtronicTalks Podcast, host Tom Salemi speaks with two of the principal architects of Medtronic's move to reduce i's impact on the globe.
Ginny Cassidy, director of the Enterprise Sustainability Program at the company, explains why executives and investors at companies need to understand their TOTAL impact on the environment. She also shares ways Medtronic devices can help others reduce their own impacts.
Nate Pommier, senior environmental, health and safety manager for the EHS Services department, details how changes in packaging and other efforts are making a difference. He also explains why environmental awareness can help...2021-04-2135 min
DeviceTalks Podcast NetworkDigging into the Digital Medtech & Surgical Worlds with Mark Toland, Scott Huennekens, and Kal PatelThis week we’ll dig deep into digital surgery, robotics and the power of THE CLOUD.
In our opening keynote conversation, Mark Toland, CEO of Medical Micro Instruments, explains why the company’s microsurgical robot has a chance to be in most hospitals. The company has CE Mark, a controlled commercial roll out and plans to knock in the FDA’s door sometime in 2022 where it will face huge competition (or, we think, potential acquirers if history holds out.) Watch the cool CNBC video here. https://www.cnbc.com/2020/10/28/italy-symani-surgical-robotic-system-improves-microsurgery-procedures.html
Next, we talk with Scott “Go Go Go” Huennekens, employee n...2021-01-161h 08DeviceTalks Podcast NetworkDigging into the Digital Medtech & Surgical Worlds with Mark Toland, Scott Huennekens, and Kal PatelThis week we’ll dig deep into digital surgery, robotics and the power of THE CLOUD.
In our opening keynote conversation, Mark Toland, CEO of Medical Micro Instruments, explains why the company’s microsurgical robot has a chance to be in most hospitals. The company has CE Mark, a controlled commercial roll out and plans to knock in the FDA’s door sometime in 2022 where it will face huge competition (or, we think, potential acquirers if history holds out.) Watch the cool CNBC video here. https://www.cnbc.com/2020/10/28/italy-symani-surgical-robotic-system-improves-microsurgery-procedures.html
Next, we talk with Scott “Go Go Go” Huennekens, employee n...2021-01-161h 08
DeviceTalks Podcast NetworkMedtronic’s Kowal on remote tech’s rebirth, SVB’s Norris delivers good news for VCs, CEOsDr. Robert Kowal, CMO of Medtronic’s cardiac rhythm and heart failure business and vice president of medical affairs, explains how new tech, savvy patients, eager physicians and, yes, COVID-19, has fueled a renaissance for remote technology, once seen as a mature, staid business. Dr. Kowal also shares an amazing story of a patient who may owe his life to a timely conversation between his pacemaker and cellphone.
Jon Norris, managing director of healthcare at Silicon Valley Bank, delivers three big takeaways from his report on 2020 fundraising. Medtech venture capitalists and start-ups didn’t let the lockdown slow their fund-raising effo...2021-01-0850 minDeviceTalks Podcast NetworkMedtronic’s Kowal on remote tech’s rebirth, SVB’s Norris delivers good news for VCs, CEOsDr. Robert Kowal, CMO of Medtronic’s cardiac rhythm and heart failure business and vice president of medical affairs, explains how new tech, savvy patients, eager physicians and, yes, COVID-19, has fueled a renaissance for remote technology, once seen as a mature, staid business. Dr. Kowal also shares an amazing story of a patient who may owe his life to a timely conversation between his pacemaker and cellphone.
Jon Norris, managing director of healthcare at Silicon Valley Bank, delivers three big takeaways from his report on 2020 fundraising. Medtech venture capitalists and start-ups didn’t let the lockdown slow their fund-raising effo...2021-01-0850 min
DeviceTalks Podcast NetworkTaking the fight to COVID-19 - BD, DHL, Novant on delivering, shipping and administering the vaccineHappy Vaccine Week!
This week, we’ll visit with the medtech professionals who are working to get the vaccines into the right hands – and arms – of the people who need it most.
This week’s guests include
• Elizabeth Woody, Senior Vice President, Public Affairs at BD
• Claudia Roa, Vice President Life Science & Healthcare Sector, Americas Global Customer Solutions at DHL
• Eric Eskioğlu, MD, EVP & Chief Medical Officer, Novant Health
Co-hosts Tom Salemi and Chris Newmarker welcome Brian Buntz, medtech pro and now pharma editor at WTWH Media, for a recap of the top 10 #newmarkersnewsmakers of 2020.
We also look ahead to 2021 offerin...2020-12-181h 08DeviceTalks Podcast NetworkTaking the fight to COVID-19 - BD, DHL, Novant on delivering, shipping and administering the vaccineHappy Vaccine Week!
This week, we’ll visit with the medtech professionals who are working to get the vaccines into the right hands – and arms – of the people who need it most.
This week’s guests include
• Elizabeth Woody, Senior Vice President, Public Affairs at BD
• Claudia Roa, Vice President Life Science & Healthcare Sector, Americas Global Customer Solutions at DHL
• Eric Eskioğlu, MD, EVP & Chief Medical Officer, Novant Health
Co-hosts Tom Salemi and Chris Newmarker welcome Brian Buntz, medtech pro and now pharma editor at WTWH Media, for a recap of the top 10 #newmarkersnewsmakers of 2020.
We also look ahead to 2021 offerin...2020-12-181h 08
DeviceTalks Podcast NetworkSmith & Nephew's Ortho President Kiil, Rhaeos CEO Somera's Big Win, and Medtronic's LegacyIn this week’s DeviceTalks Weekly Podcast, our opening and closing keynote interviews focus on executives at companies from very different stages.
MANUFACTURING AND SOURCING: Skip Kiil took the helm of Smith + Nephew’s global orthopedics business to transform the business. The company’s recent acquisition of Integra’s extremities will further that mission. In our closing keynote conversation, the president of orthopedics updates us on the new technologies and tools that Smith + Nephew is rolling out to help orthopedic patients.
Kiil will hit upon Smith + Nephew’s:
• CORI Robotics surgical tools
• Real Intelligence platform
• Interest in Ambulatory Surgery Centers
• Balance of OUS vs...2020-10-0954 minDeviceTalks Podcast NetworkSmith & Nephew's Ortho President Kiil, Rhaeos CEO Somera's Big Win, and Medtronic's LegacyIn this week’s DeviceTalks Weekly Podcast, our opening and closing keynote interviews focus on executives at companies from very different stages.
MANUFACTURING AND SOURCING: Skip Kiil took the helm of Smith + Nephew’s global orthopedics business to transform the business. The company’s recent acquisition of Integra’s extremities will further that mission. In our closing keynote conversation, the president of orthopedics updates us on the new technologies and tools that Smith + Nephew is rolling out to help orthopedic patients.
Kiil will hit upon Smith + Nephew’s:
• CORI Robotics surgical tools
• Real Intelligence platform
• Interest in Ambulatory Surgery Centers
• Balance of OUS vs...2020-10-0954 min
DeviceTalks Podcast NetworkAvail Medsystems, AliveCor help surgeons, patients, and sales reps battle COVID through connectivityIn a double dose of New Tools and Technology interviews, co-host Tom Salemi talks with two companies using connective technology to build out innovative service businesses.
Medtech veteran Daniel Hawkins, CEO of Avail Medsystems, creator of a procedural telemedicine system that can open up the operating room for sales reps and surgical experts. Hawkins explains how Avail will provide the equipment to hospitals for free while creating new channels for medical device companies to advise surgeons in the operating room. You can learn more about Avail’s approach on our upcoming DeviceTalks Tuesday episode on Oct. 6. https://www.devicetalks.com/devi...2020-10-0337 minDeviceTalks Podcast NetworkAvail Medsystems, AliveCor help surgeons, patients, and sales reps battle COVID through connectivityIn a double dose of New Tools and Technology interviews, co-host Tom Salemi talks with two companies using connective technology to build out innovative service businesses.
Medtech veteran Daniel Hawkins, CEO of Avail Medsystems, creator of a procedural telemedicine system that can open up the operating room for sales reps and surgical experts. Hawkins explains how Avail will provide the equipment to hospitals for free while creating new channels for medical device companies to advise surgeons in the operating room. You can learn more about Avail’s approach on our upcoming DeviceTalks Tuesday episode on Oct. 6. https://www.devicetalks.com/devi...2020-10-0337 min
DeviceTalks Podcast NetworkCan Boston Scientific Close the Gap in healthcare? Innovator Jeff Karp, MD, shares early challengesMedtech People: In this week’s DeviceTalks Weekly Podcast, we’ll talk about overcoming unfairness and inequity.
In our keynote interview, Boston Scientific’s Camille Chang Gilmore, vice president, human resources, global chief diversity officer, and Michael Jaff, MD, CMO of its peripheral vascular group, reintroduce us to the company’s Close the Gap program. Launched in 2006, Close the Gap seeks to address the lack of care being delivered to underserved populations, including people of color and people earning lower incomes. The two Boston Science executives will explain why Close the Gap is more essential than ever, and what we as an in...2020-09-2645 minDeviceTalks Podcast NetworkCan Boston Scientific Close the Gap in healthcare? Innovator Jeff Karp, MD, shares early challengesMedtech People: In this week’s DeviceTalks Weekly Podcast, we’ll talk about overcoming unfairness and inequity.
In our keynote interview, Boston Scientific’s Camille Chang Gilmore, vice president, human resources, global chief diversity officer, and Michael Jaff, MD, CMO of its peripheral vascular group, reintroduce us to the company’s Close the Gap program. Launched in 2006, Close the Gap seeks to address the lack of care being delivered to underserved populations, including people of color and people earning lower incomes. The two Boston Science executives will explain why Close the Gap is more essential than ever, and what we as an in...2020-09-2645 min
DeviceTalks Podcast NetworkAmbu, Boston Scientific in the first single-use DeviceTalks Weekly– No sterilization necessaryMANUFACTURING & SOURCING: This week, the DeviceTalks Weekly Podcast explores the potential of single-use endoscopes. Co-host Tom Salemi interviews leaders from the leaders – Ambu and Boston Scientific. First, Ambu CEO Juan Jose Gonzalez and Stephen Block, president of Ambu US, introduce us to one of medtech’s fastest growing companies. Ambu is moving into the single-use market with a less expensive alternative to those offered by larger rival Boston Scientific. We’ll find how Gonzalez and Block view the opportunity. In our second interview, we dig into the EXALT offering with Boston Scientific’s CMO Brian Dunkin, MD and Dave Pierce, EVP and...2020-09-1254 minDeviceTalks Podcast NetworkAmbu, Boston Scientific in the first single-use DeviceTalks Weekly– No sterilization necessaryMANUFACTURING & SOURCING: This week, the DeviceTalks Weekly Podcast explores the potential of single-use endoscopes. Co-host Tom Salemi interviews leaders from the leaders – Ambu and Boston Scientific. First, Ambu CEO Juan Jose Gonzalez and Stephen Block, president of Ambu US, introduce us to one of medtech’s fastest growing companies. Ambu is moving into the single-use market with a less expensive alternative to those offered by larger rival Boston Scientific. We’ll find how Gonzalez and Block view the opportunity. In our second interview, we dig into the EXALT offering with Boston Scientific’s CMO Brian Dunkin, MD and Dave Pierce, EVP and...2020-09-1254 min
DeviceTalks Podcast NetworkCan Fractyl Labs and Cala Health go where only drugs have gone before?In this week’s episode of the DeviceTalks Weekly podcast, co-hosts Tom Salemi, editorial director of DeviceTalks, and Chris Newmarker, executive editor of life sciences, review this week's Top 5 medtech stories, aka “Newmarker’s Newsmakers,” with news coming from CureVac, Avail Medsystems, ClearMask, Thermo Fisher and Bayer.
We also hear from two executives from Fractyl Laboratories — CEO Dr. Harith Rajagopalan and CFO Lisa Davidson — about its recent $55 million Series E round of financing and the strides they're making in developing a device to treat diabetes.
In a second interview, Cala Health CEO Renee Ryan gives us an update on the Cala Trio’s...2020-08-2150 minDeviceTalks Podcast NetworkCan Fractyl Labs and Cala Health go where only drugs have gone before?In this week’s episode of the DeviceTalks Weekly podcast, co-hosts Tom Salemi, editorial director of DeviceTalks, and Chris Newmarker, executive editor of life sciences, review this week's Top 5 medtech stories, aka “Newmarker’s Newsmakers,” with news coming from CureVac, Avail Medsystems, ClearMask, Thermo Fisher and Bayer.
We also hear from two executives from Fractyl Laboratories — CEO Dr. Harith Rajagopalan and CFO Lisa Davidson — about its recent $55 million Series E round of financing and the strides they're making in developing a device to treat diabetes.
In a second interview, Cala Health CEO Renee Ryan gives us an update on the Cala Trio’s...2020-08-2150 min
DeviceTalks Podcast NetworkWhat in the world will Thrive Earlier Detection do with $257 million?In this week’s podcast, two executives from Thrive Earlier Detection explain how the “turbo-charged” diagnostics company intends to upend how, when and where cancer is diagnosed. Isaac Kinde, MD, PhD, co-founder and head of research and innovation, walks us through the company’s CancerSEEK test and how the company is marrying new technology with an innovative clinical approach. Meanwhile, Isaac Ro, tells host Tom Salemi how the company closed on $257 million (hint: lots of Zoom) and why he left a career on Wall Street to join this innovative start-up.
Chris Newmarker, executive editor of life sciences at MassDevice, also counts d...2020-08-0140 minDeviceTalks Podcast NetworkWhat in the world will Thrive Earlier Detection do with $257 million?In this week’s podcast, two executives from Thrive Earlier Detection explain how the “turbo-charged” diagnostics company intends to upend how, when and where cancer is diagnosed. Isaac Kinde, MD, PhD, co-founder and head of research and innovation, walks us through the company’s CancerSEEK test and how the company is marrying new technology with an innovative clinical approach. Meanwhile, Isaac Ro, tells host Tom Salemi how the company closed on $257 million (hint: lots of Zoom) and why he left a career on Wall Street to join this innovative start-up.
Chris Newmarker, executive editor of life sciences at MassDevice, also counts d...2020-08-0140 min
DeviceTalks Podcast NetworkCan Drawbridge, Edwards bring disruptive innovation to blood drawing, heart surgery industries?In this week’s podcast, we talk with Holly Logue, general counsel at Drawbridge Health, about the OneDraw, an innovative new tool that might upend the collecting, storage and testing of blood. Logue, a panelist in the upcoming DeviceTalks Tuesdays sponsored by Finnegan, will explain how her past work on Capitol Hill is helping this Silicon Valley company’s plans.
Meanwhile, we speak with Daveen Chopra, corporate vice president of surgical structural heart at Edwards Lifesciences, about that company’s commitment to treating the most serious cardiac patients. The company recently won FDA approval for its Konect Resilia aortic valve condui...2020-07-2440 minDeviceTalks Podcast NetworkCan Drawbridge, Edwards bring disruptive innovation to blood drawing, heart surgery industries?In this week’s podcast, we talk with Holly Logue, general counsel at Drawbridge Health, about the OneDraw, an innovative new tool that might upend the collecting, storage and testing of blood. Logue, a panelist in the upcoming DeviceTalks Tuesdays sponsored by Finnegan, will explain how her past work on Capitol Hill is helping this Silicon Valley company’s plans.
Meanwhile, we speak with Daveen Chopra, corporate vice president of surgical structural heart at Edwards Lifesciences, about that company’s commitment to treating the most serious cardiac patients. The company recently won FDA approval for its Konect Resilia aortic valve condui...2020-07-2440 min
DeviceTalks Podcast NetworkCVRx CEO Nadim Yared on his path from engineer to CEO to industry leader.Nadim Yared, CEO of CVRx
This week, CVRX reported positive six-month trial results for its Barostim Neo, an FDA-approved treatment for heart failure.
The results follow years of close work between the agency and CVRx, one of the more ambitious startups in medtech. CVRx is targeting a huge clinical need with novel neuromodulation technology.
In this week’s DeviceTalks Weekly podcast, CEO Nadim Yared walks us through the negotiations the company went through with the FDA to get to this point.
Yared, the prior chairman of the industry group AdvaMed, also shares the story of his career, which started early on...2020-07-0347 minDeviceTalks Podcast NetworkCVRx CEO Nadim Yared on his path from engineer to CEO to industry leader.Nadim Yared, CEO of CVRx
This week, CVRX reported positive six-month trial results for its Barostim Neo, an FDA-approved treatment for heart failure.
The results follow years of close work between the agency and CVRx, one of the more ambitious startups in medtech. CVRx is targeting a huge clinical need with novel neuromodulation technology.
In this week’s DeviceTalks Weekly podcast, CEO Nadim Yared walks us through the negotiations the company went through with the FDA to get to this point.
Yared, the prior chairman of the industry group AdvaMed, also shares the story of his career, which started early on...2020-07-0347 min
DeviceTalks Podcast NetworkWhy FDA put the pedal to the metal for radar and hummingbirds. And why medtech needs Google.DeviceTalks Weekly: Ep. 15 – Why FDA put the pedal to the metal for radar and hummingbirds. And why medtech needs Google.
In this week’s episode of DeviceTalks Weekly, co-hosts Chris Newmarker and Tom Salemi dig into the recent successes by start-ups Circadia Health and Perceptis Medical, which both saw expedited approval from the FDA due to the pandemic.
We also unveil the 20 medical device companies you need to know.
https://www.medicaldesignandoutsourcing.com/20-medical-device-startups-you-need-to-know-2020/
Circadia CEO Fares Siddiqui discusses the quick approval that came for his company’s C100 system that uses radar to monitor respiratory function. Preceptis Medical CEO Steve...2020-06-2737 minDeviceTalks Podcast NetworkWhy FDA put the pedal to the metal for radar and hummingbirds. And why medtech needs Google.DeviceTalks Weekly: Ep. 15 – Why FDA put the pedal to the metal for radar and hummingbirds. And why medtech needs Google.
In this week’s episode of DeviceTalks Weekly, co-hosts Chris Newmarker and Tom Salemi dig into the recent successes by start-ups Circadia Health and Perceptis Medical, which both saw expedited approval from the FDA due to the pandemic.
We also unveil the 20 medical device companies you need to know.
https://www.medicaldesignandoutsourcing.com/20-medical-device-startups-you-need-to-know-2020/
Circadia CEO Fares Siddiqui discusses the quick approval that came for his company’s C100 system that uses radar to monitor respiratory function. Preceptis Medical CEO Steve...2020-06-2737 min
DeviceTalks Podcast NetworkCala Health CEO Renee Ryan Brings Business Building Insights to Bioelectronic Medicine StartupDeviceTalks Weekly: Ep. 13 – Cala Health CEO Renee Ryan Brings Business Building Insights to Bioelectronic Medicine Startup
In this week’s episode of DeviceTalks Weekly, Tom Salemi, editorial director of DeviceTalks events and content, visits with Renee Ryan, the CEO of neuromodulation startup Cala Health.
Ryan came to Cala from the venerable medtech investor Johnson & Johnson Development Corp., where she made over 15 investments helping to create companies including Auris Surgical, Cala and digital surgery play Verb Surgical, J&J’s joint venture with Verily. “I really set my mind to [asking] was there a way we could create our own opportunities,” she said of...2020-06-1232 minDeviceTalks Podcast NetworkCala Health CEO Renee Ryan Brings Business Building Insights to Bioelectronic Medicine StartupDeviceTalks Weekly: Ep. 13 – Cala Health CEO Renee Ryan Brings Business Building Insights to Bioelectronic Medicine Startup
In this week’s episode of DeviceTalks Weekly, Tom Salemi, editorial director of DeviceTalks events and content, visits with Renee Ryan, the CEO of neuromodulation startup Cala Health.
Ryan came to Cala from the venerable medtech investor Johnson & Johnson Development Corp., where she made over 15 investments helping to create companies including Auris Surgical, Cala and digital surgery play Verb Surgical, J&J’s joint venture with Verily. “I really set my mind to [asking] was there a way we could create our own opportunities,” she said of...2020-06-1232 min
DeviceTalks Podcast NetworkDTW's Commencement Speaker- Todd Brinton, MD, Edwards Lifesciences on building a career in medtechIn this week’s DeviceTalks Weekly podcast, we attempt to deliver heartfelt and hard won advice in a sort of commencement address by Todd Brinton, MD, Corporate Vice President,
Advanced Technology and Chief Scientific Officer of Edwards Lifesciences. Dr. Brinton sits down with host Tom Salemi to share his path into Medtech. Brinton shares great advice for anyone looking for a new career or opportunity in medtech. NOTE: This conversation was recorded in March, prior to the full impact of the COVID-19 pandemic.2020-05-3049 minDeviceTalks Podcast NetworkDTW's Commencement Speaker- Todd Brinton, MD, Edwards Lifesciences on building a career in medtechIn this week’s DeviceTalks Weekly podcast, we attempt to deliver heartfelt and hard won advice in a sort of commencement address by Todd Brinton, MD, Corporate Vice President,
Advanced Technology and Chief Scientific Officer of Edwards Lifesciences. Dr. Brinton sits down with host Tom Salemi to share his path into Medtech. Brinton shares great advice for anyone looking for a new career or opportunity in medtech. NOTE: This conversation was recorded in March, prior to the full impact of the COVID-19 pandemic.2020-05-3049 min
DeviceTalks Podcast NetworkDeviceTalks Weekly: Ep. 9 – What’s the state of the Medtech job market?In this week’s episode of DeviceTalks Weekly, Tom Salemi speaks with two executive recruiters about what they see in the medtech market. Over the past month, we’ve seen several medtech companies – big and small – cutting jobs and reducing hours but what does this mean long-term.
In this podcast we’ll identify a few companies that are hiring, but we’ll talk in-depth with the recruiters about…
• How bad is the current market?
• What’s the likelihood for recovery?
• What skills are in greater demand?
• What can people do to strengthen their hand?
Guests are:
• David L. Vied, global sector leader, Global Sect...2020-05-0832 minDeviceTalks Podcast NetworkDeviceTalks Weekly: Ep. 9 – What’s the state of the Medtech job market?In this week’s episode of DeviceTalks Weekly, Tom Salemi speaks with two executive recruiters about what they see in the medtech market. Over the past month, we’ve seen several medtech companies – big and small – cutting jobs and reducing hours but what does this mean long-term.
In this podcast we’ll identify a few companies that are hiring, but we’ll talk in-depth with the recruiters about…
• How bad is the current market?
• What’s the likelihood for recovery?
• What skills are in greater demand?
• What can people do to strengthen their hand?
Guests are:
• David L. Vied, global sector leader, Global Sect...2020-05-0832 min
DeviceTalks Podcast NetworkDeviceTalks Weekly: Ep.7 – Edwards, Employment News, Update on Clinical Trials from AvaniaIn this week’s episode of DeviceTalks Weekly, Tom Salemi and Chris Newmarker stare at each other through the Zoom lens while talking about the positive news from Baxter and Conformis, the hopeful projections from Edwards, and the cautionary tone from Medtronic.
We also interview Mark McIlduff, general manager, US, at the newly named CRO, Avania on the state of clinical trials. What changes might we expect in the future? Mark brings great insights.
Guests are:
• Mark McIlduff, general manager, US, Avania
Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.2020-04-2534 minDeviceTalks Podcast NetworkDeviceTalks Weekly: Ep.7 – Edwards, Employment News, Update on Clinical Trials from AvaniaIn this week’s episode of DeviceTalks Weekly, Tom Salemi and Chris Newmarker stare at each other through the Zoom lens while talking about the positive news from Baxter and Conformis, the hopeful projections from Edwards, and the cautionary tone from Medtronic.
We also interview Mark McIlduff, general manager, US, at the newly named CRO, Avania on the state of clinical trials. What changes might we expect in the future? Mark brings great insights.
Guests are:
• Mark McIlduff, general manager, US, Avania
Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.2020-04-2534 min
DeviceTalks Podcast NetworkDeviceTalks Weekly, Ep. 2 - Medtech goes to WarIn this week’s DeviceTalks Weekly Podcast, hosts Tom Salemi and Chris Newmarker will detail medtech’s essential role in the escalating war against COVID-19. This week’s guests are Fluidda CEO Jan De Backer and Kevin Thornal, division president of diagnostic solutions at Hologic. The executive will explain how their new FDA tools will aid against the diagnosis and treatment of COVID-19. We also ask them how the recently invoked Defense Production Act will impact medtech’s fight against the pandemic.2020-03-2032 minDeviceTalks Podcast NetworkDeviceTalks Weekly, Ep. 2 - Medtech goes to WarIn this week’s DeviceTalks Weekly Podcast, hosts Tom Salemi and Chris Newmarker will detail medtech’s essential role in the escalating war against COVID-19. This week’s guests are Fluidda CEO Jan De Backer and Kevin Thornal, division president of diagnostic solutions at Hologic. The executive will explain how their new FDA tools will aid against the diagnosis and treatment of COVID-19. We also ask them how the recently invoked Defense Production Act will impact medtech’s fight against the pandemic.2020-03-2032 min
DeviceTalks Podcast NetworkDeviceTalks Weekly, Episode 1, - Raj Denhoy, JefferiesWelcome to the DeviceTalks Weekly Podcast, a regular – and sometimes irregular – opportunity to visit with the editorial team at MassDevice and Medical Design and Outsourcing. This week, Chris Newmarker, Executive Editor, Life Sciences, at WTWH Media, reviews our COVID-19 coverage with Tom Salemi, Editorial Director, DeviceTalks. Tom also chats with Raj Denhoy, Managing Director, Equity Research Analyst at Jefferies, who details how the Medtech sector is fairing in this unprecedented uncertainty. While most Medtechs stand on strong financial footing, Denhoy issues a warning to investors that another correction may be coming once analysts start assessing the impact on earnings. Still, he s...2020-03-1626 minDeviceTalks Podcast NetworkDeviceTalks Weekly, Episode 1, - Raj Denhoy, JefferiesWelcome to the DeviceTalks Weekly Podcast, a regular – and sometimes irregular – opportunity to visit with the editorial team at MassDevice and Medical Design and Outsourcing. This week, Chris Newmarker, Executive Editor, Life Sciences, at WTWH Media, reviews our COVID-19 coverage with Tom Salemi, Editorial Director, DeviceTalks. Tom also chats with Raj Denhoy, Managing Director, Equity Research Analyst at Jefferies, who details how the Medtech sector is fairing in this unprecedented uncertainty. While most Medtechs stand on strong financial footing, Denhoy issues a warning to investors that another correction may be coming once analysts start assessing the impact on earnings. Still, he s...2020-03-1626 min
OIS Podcast | Ophthalmology's leading PodcastDid You Miss OIS Retina (or Just Miss Being in Vancouver?) Hear Highlights from the Meeting FloorOIS Podcast Host Tom Salemi Speaks with Investors Greg Grunberg, MD, and Firas Rihhal, MD, as well as OIS Contributors Richard Mark Kirkner and Bérénice Magistretti about some of the key takeaways for investors, physicians and patients.2018-08-0231 min
Breaking HealthCo-Chairs Geary, Mittendorff Share High Notes from a Successful Digital Healthcare Innovation SummitIn this week’s podcast, Breaking Health co-host Tom Salemi catches up with summit co-chairs Bill Geary and Robert Mittendorff, MD, immediately after the close of the sold-out Digital Healthcare Innovation Summit. The trio share their highlights from the summit including lessons from former GE CEO Jeff Immelt and broader observations about the maturation of Digital Health.2017-12-0508 min
Breaking HealthThe DHIS Post Game ShowThe Digital Healthcare Innovation Summit brought together over 300 leaders in Digital Technology and Health Care to dig into what will finally bring real change to health care. The message is clear – change is coming. EMRs are up and running. Health care workers are demanding mobile technologies. And physicians find telehealth visits to be a viable – and cost effective way – of managing patient health. All discussions as well as private interviews with health care leaders will be available at digitalhealthcaresummit.com. Until they arrive, listen to Healthegy Content Director Tom Salemi and Steve Krupa, CEO of Psilos Group and host of Breaki...2015-11-0525 min